Cargando…
Current Management of Urachal Carcinoma: An Evidence-based Guide for Clinical Practice
Urachal carcinoma is a rare urological disease. The shortage of data about diagnosis and surgical treatment in literature makes it hard for clinicians to make a decision. Indeed, urachal carcinoma is an aggressive disease that requires prompt staging and treatment to ensure the best outcome for pati...
Autores principales: | Loizzo, Davide, Pandolfo, Savio D., Crocerossa, Fabio, Guruli, Georgi, Ferro, Matteo, Paul, Asit K., Imbimbo, Ciro, Lucarelli, Giuseppe, Ditonno, Pasquale, Autorino, Riccardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927909/ https://www.ncbi.nlm.nih.gov/pubmed/35309098 http://dx.doi.org/10.1016/j.euros.2022.02.009 |
Ejemplares similares
-
The impact the COVID-19 pandemic on urology literature: a bibliometric analysis
por: Crocerossa, Fabio, et al.
Publicado: (2022) -
Photodynamic Diagnosis-guided Transurethral Resection of Bladder Tumour in Participants with a First Suspected Diagnosis of Intermediate- or High-risk Non–muscle-invasive Bladder Cancer: Cost-effectiveness Analysis Alongside a Randomised Controlled Trial
por: Yu, Ge, et al.
Publicado: (2023) -
Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers
por: Lasorsa, Francesco, et al.
Publicado: (2023) -
Role of Serum Lymphocyte-derived Biomarkers in Nonmetastatic Muscle-invasive Bladder Cancer Patients Treated with Trimodal Therapy
por: Kool, Ronald, et al.
Publicado: (2021) -
Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer
por: di Meo, Nicola Antonio, et al.
Publicado: (2022)